Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL

• Main Authors: Zhengping Li (Author), Jie Sun (Author), Zekun Li (Author), Zhenping Chen (Author), Guoqing Liu (Author), Wanru Yao (Author), Xiaoling Cheng (Author), Gang Li (Author), Yingzi Zhen (Author), Di Ai (Author), Yaohan Zhou (Author), Qianqian Mao (Author), Man‐Chiu Poon (Author), Runhui Wu (Author)
• Format: Book
• Published: Wiley, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT Importance It remained unclear that the efficacy comparison between low‐dose immune tolerance induction (LD‐ITI) incorporating immunosuppressants (IS) when severe hemophilia A (SHA) patients had inhibitor‐titer ≥200 Bethesda Units (BU)/mL (LD‐ITI‐IS200 regimen) and LD‐ITI combining with IS...